Alcat Based Elimination Diet for the Treatment of Irritable Bowel Syndrome; a Randomized Double Blind Sham Control Trial

计划入组 70 人 · 首次发布于 2022 年 11 月 15 日

Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease

计划入组 534 人 · 首次发布于 2005 年 9 月 16 日

Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Carotid Artery Disease. This Study is Also Known as CAPTIVATE.

计划入组 796 人 · 首次发布于 2005 年 9 月 9 日

ACAT inhibitor (Kyoto)

ACAT inhibitor(Pfizer Inc.)

ACAT inhibitors( Kyoto Pharmaceutical Industries Ltd.)

SandboxAQ to Bring Physics-Grounded Drug Discovery Models to Google Cloud Marketplace

Google Cloud to Offer SandboxAQ's Large Quantitative AI Models for Drug Discovery via Marketplace